7 results
Algorithm for the Long-Term Treatment of Venous Thromboembolism 

Reference: https://doi.org/10.1182/blood.2019002364

by Dr. Clive Kearon and Dr. Susan
the Long-Term Treatment ... SusanRKahn1 #LongTerm ... #Treatment #Venous ... Thromboembolism #VTE ... Anticoagulation #Algorithm #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... risk of recurrent VTE ... #Cancer #Algorithm ... Anticoagulation #Management #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology
Duration of Treatment of Venous Thromboembolism (VTE)
 - Major transient risk factor (eg, major surgery, major
Duration of Treatment ... Thromboembolism (VTE ... or as long as cancer ... , whichever is longer ... #Duration #Treatment
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Consensus 2019: Duration ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... management #DVT #hematology ... #length #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism Treatment ... therapy - Second VTE ... Thromboembolism #Treatment ... Algorithm #management #hematology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... Chemotherapy #Oncology #Hematology ... #Interactions #Table